scispace - formally typeset
J

Joanna Schaenman

Researcher at University of California, Los Angeles

Publications -  84
Citations -  1053

Joanna Schaenman is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 16, co-authored 61 publications receiving 764 citations. Previous affiliations of Joanna Schaenman include UCLA Medical Center & Stanford University.

Papers
More filters
Journal ArticleDOI

Report from the American Society of Transplantation on frailty in solid organ transplantation

TL;DR: This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.
Journal ArticleDOI

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

TL;DR: Overall survival and freedom from progression at 4 years for chronic lymphocytic leukemia patients were 73% and 47%, respectively; for mantle-cell lymphoma patients, they were 69% and 53%, respectively.
Journal ArticleDOI

Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

TL;DR: These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of adenovirus infections after solid organ transplantation and highlight that adenvirus surveillance testing should not be performed in asymptomatic recipients.
Journal ArticleDOI

BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions

TL;DR: In the absence of conclusive evidence that any particular immunosuppressive agent has a specific influence over another on BKV infection risk and the unclear benefit of antiviral agents, intensive monitoring of serum BkV using PCR and immunological containment of BKv replication should remain the mainstay of therapy.
Journal ArticleDOI

Identification and Characterization of anEntamoeba histolytica Upstream Regulatory Element 3 Sequence-specific DNA-binding Protein Containing EF-hand Motifs

TL;DR: These results represent the first use of a yeast genetic screen to identify a DNA-binding protein of an early branching eukaryote on the basis of function, and may provide insight into transcription regulation and virulence control in this parasite.